4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide

C120H121Cl9F2N22O15S5 — CID 158760193

IUPAC4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide
SMILESCC(C)(O)C(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3Cl)nc3ccc(NS(C)(=O)=O)cn23)CC1.CN(c1ccc2nc(-c3ccc(Cl)cc3Cl)c(CN3CCN(C(=O)c4ccc(F)cc4)CC3)n2c1)S(C)(=O)=O.CS(=O)(=O)Nc1ccc2nc(-c3ccc(Cl)cc3Cl)c(CN3CCCOCC3)n2c1.CS(=O)(=O)Nc1ccc2nc(-c3ccc(Cl)cc3Cl)c(CN3CCN(C(=O)c4ccc(F)cc4)CC3)n2c1.O=S1(=O)CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn23)CC1
InChIInChI=1S/C27H26Cl2FN5O3S.C26H24Cl2FN5O3S.C24H22ClN3O2S.C23H27Cl2N5O4S.C20H22Cl2N4O3S/c1-32(39(2,37)38)21-8-10-25-31-26(22-9-5-19(28)15-23(22)29)24(35(25)16-21)17-33-11-13-34(14-12-33)27(36)18-3-6-20(30)7-4-18;1-38(36,37)31-20-7-9-24-30-25(21-8-4-18(27)14-22(21)28)23(34(24)15-20)16-32-10-12-33(13-11-32)26(35)17-2-5-19(29)6-3-17;25-21-9-6-19(7-10-21)24-22(17-27-12-14-31(29,30)15-13-27)28-16-20(8-11-23(28)26-24)18-4-2-1-3-5-18;1-23(2,32)22(31)29-10-8-28(9-11-29)14-19-21(17-6-4-15(24)12-18(17)25)26-20-7-5-16(13-30(19)20)27-35(3,33)34;1-30(27,28)24-15-4-6-19-23-20(16-5-3-14(21)11-17(16)22)18(26(19)12-15)13-25-7-2-9-29-10-8-25/h3-10,15-16H,11-14,17H2,1-2H3;2-9,14-15,31H,10-13,16H2,1H3;1-11,16H,12-15,17H2;4-7,12-13,27,32H,8-11,14H2,1-3H3;3-6,11-12,24H,2,7-10,13H2,1H3
InChIKeyIOOKPIUQJRQDIR-UHFFFAOYSA-N
MW2628.83 g/mol
LogP21.13
Rot. Bonds27

About 4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide

4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide (PubChem CID 158760193) has the molecular formula C120H121Cl9F2N22O15S5 and a molecular weight of 2628.83 g/mol. Its IUPAC name is 4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide.

Molecular Properties

Compound Name4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide
PubChem CID158760193
Molecular FormulaC120H121Cl9F2N22O15S5
Molecular Weight2628.83 g/mol
Exact Mass2622.52
IUPAC Name4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide
SMILESCC(C)(O)C(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3Cl)nc3ccc(NS(C)(=O)=O)cn23)CC1.CN(c1ccc2nc(-c3ccc(Cl)cc3Cl)c(CN3CCN(C(=O)c4ccc(F)cc4)CC3)n2c1)S(C)(=O)=O.CS(=O)(=O)Nc1ccc2nc(-c3ccc(Cl)cc3Cl)c(CN3CCCOCC3)n2c1.CS(=O)(=O)Nc1ccc2nc(-c3ccc(Cl)cc3Cl)c(CN3CCN(C(=O)c4ccc(F)cc4)CC3)n2c1.O=S1(=O)CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn23)CC1
InChIInChI=1S/C27H26Cl2FN5O3S.C26H24Cl2FN5O3S.C24H22ClN3O2S.C23H27Cl2N5O4S.C20H22Cl2N4O3S/c1-32(39(2,37)38)21-8-10-25-31-26(22-9-5-19(28)15-23(22)29)24(35(25)16-21)17-33-11-13-34(14-12-33)27(36)18-3-6-20(30)7-4-18;1-38(36,37)31-20-7-9-24-30-25(21-8-4-18(27)14-22(21)28)23(34(24)15-20)16-32-10-12-33(13-11-32)26(35)17-2-5-19(29)6-3-17;25-21-9-6-19(7-10-21)24-22(17-27-12-14-31(29,30)15-13-27)28-16-20(8-11-23(28)26-24)18-4-2-1-3-5-18;1-23(2,32)22(31)29-10-8-28(9-11-29)14-19-21(17-6-4-15(24)12-18(17)25)26-20-7-5-16(13-30(19)20)27-35(3,33)34;1-30(27,28)24-15-4-6-19-23-20(16-5-3-14(21)11-17(16)22)18(26(19)12-15)13-25-7-2-9-29-10-8-25/h3-10,15-16H,11-14,17H2,1-2H3;2-9,14-15,31H,10-13,16H2,1H3;1-11,16H,12-15,17H2;4-7,12-13,27,32H,8-11,14H2,1-3H3;3-6,11-12,24H,2,7-10,13H2,1H3
InChIKeyIOOKPIUQJRQDIR-UHFFFAOYSA-N
XLogP21.13
TPSA403.12 Ų
H-Bond Donors4
H-Bond Acceptors30
Rotatable Bonds27
Heavy Atoms173
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002628.83
LogP ≤ 521.13
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1030

Analyze 4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide?
The IUPAC name of 4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide (CID 158760193) is 4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide.
What is the SMILES notation for 4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide?
The canonical SMILES for 4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide is CC(C)(O)C(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3Cl)nc3ccc(NS(C)(=O)=O)cn23)CC1.CN(c1ccc2nc(-c3ccc(Cl)cc3Cl)c(CN3CCN(C(=O)c4ccc(F)cc4)CC3)n2c1)S(C)(=O)=O.CS(=O)(=O)Nc1ccc2nc(-c3ccc(Cl)cc3Cl)c(CN3CCCOCC3)n2c1.CS(=O)(=O)Nc1ccc2nc(-c3ccc(Cl)cc3Cl)c(CN3CCN(C(=O)c4ccc(F)cc4)CC3)n2c1.O=S1(=O)CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn23)CC1.
What is the InChIKey of 4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide?
The InChIKey is IOOKPIUQJRQDIR-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H26Cl2FN5O3S.C26H24Cl2FN5O3S.C24H22ClN3O2S.C23H27Cl2N5O4S.C20H22Cl2N4O3S/c1-32(39(2,37)38)21-8-10-25-31-26(22-9-5-19(28)15-23(22)29)24(35(25)16-21)17-33-11-13-34(14-12-33)27(36)18-3-6-20(30)7-4-18;1-38(36,37)31-20-7-9-24-30-25(21-8-4-18(27)14-22(21)28)23(34(24)15-20)16-32-10-12-33(13-11-32)26(35)17-2-5-19(29)6-3-17;25-21-9-6-19(7-10-21)24-22(17-27-12-14-31(29,30)15-13-27)28-16-20(8-11-23(28)26-24)18-4-2-1-3-5-18;1-23(2,32)22(31)29-10-8-28(9-11-29)14-19-21(17-6-4-15(24)12-18(17)25)26-20-7-5-16(13-30(19)20)27-35(3,33)34;1-30(27,28)24-15-4-6-19-23-20(16-5-3-14(21)11-17(16)22)18(26(19)12-15)13-25-7-2-9-29-10-8-25/h3-10,15-16H,11-14,17H2,1-2H3;2-9,14-15,31H,10-13,16H2,1H3;1-11,16H,12-15,17H2;4-7,12-13,27,32H,8-11,14H2,1-3H3;3-6,11-12,24H,2,7-10,13H2,1H3.
What are the key properties of 4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide?
4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide has a molecular weight of 2628.83 g/mol, XLogP of 21.13, 27 rotatable bonds, 4 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-thiazinane 1,1-dioxide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(4-fluorobenzoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-[[4-(2-hydroxy-2-methylpropanoyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;N-[2-(2,4-dichlorophenyl)-3-(1,4-oxazepan-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide is sourced from PubChem (CID 158760193), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).